What is driving interest in Maze Therapeutics right now? Maze Therapeutics (MAZE) has drawn fresh attention after recent trading, with the stock closing at $46.01 and showing mixed short term moves, ...

The announcement came as a waffling statement, riddled with spelling mistakes and published on its website on the dark web, which for the past year has published vast troves of stolen internal ...

A group of scientists may have designed the world's most difficult maze. The maze, which is highlighted in a new study featured in Physical Review X, was designed using a series of different geometric ...

Cognizant, one of the largest tech and consulting companies in the Fortune 500, has confirmed it was hit by a ransomware attack. Details remain slim besides a brief statement on its site, confirming ...